Correlation Engine 2.0
Clear Search sequence regions


  • behavior (1)
  • circadian rhythms (5)
  • humans (1)
  • light (1)
  • melatonin (3)
  • orexin (1)
  • patients (1)
  • Sizes of these terms reflect their relevance to your search.

    Type 2 diabetes mellitus (T2DM) patients are at a higher risk of developing Alzheimer's disease (AD). Mounting evidence suggests the emerging important role of circadian rhythms in many diseases. Circadian rhythm disruption is considered to contribute to both T2DM and AD. Here, we review the relationship among circadian rhythm disruption, T2DM and AD, and suggest that the occurrence and progression of T2DM and AD may in part be associated with circadian disruption. Then, we summarize the promising therapeutic strategies targeting circadian dysfunction for T2DM and AD, including pharmacological treatment such as melatonin, orexin, and circadian molecules, as well as non-pharmacological treatments like light therapy, feeding behavior, and exercise.

    Citation

    Xuemin Peng, Rongping Fan, Lei Xie, Xiaoli Shi, Kun Dong, Shujun Zhang, Jing Tao, Weijie Xu, Delin Ma, Juan Chen, Yan Yang. A Growing Link between Circadian Rhythms, Type 2 Diabetes Mellitus and Alzheimer's Disease. International journal of molecular sciences. 2022 Jan 03;23(1)

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35008933

    View Full Text